The pathway analysis also indicated that the mitochondrial UCP2 pathway, as well as the nutrient sensing mTOR signaling pathway, were inhibited in the LBW w/NAFLD subjects compared with the NBW controls. Here, MTOR is linked to metabolic dysfunction-associated steatotic liver disease.